- Home
- HGV vs RLAY Comparison
HGV vs RLAY Comparison
Compare HGV & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HGV | RLAY |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.1B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HGV | RLAY |
|---|---|---|
| Price | $49.56 | $18.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $52.13 | $19.50 |
| AVG Volume (30 Days) | 1.1M | ★ 4.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.78 | 31.78 |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $5,047,000,000.00 | $15,355,000.00 |
| Revenue This Year | $25.30 | N/A |
| Revenue Next Year | $1.98 | $324.03 |
| P/E Ratio | $62.86 | ★ N/A |
| Revenue Growth | 1.33 | ★ 53.44 |
| 52 Week Low | $36.79 | $3.03 |
| 52 Week High | $55.40 | $20.79 |
Technical Indicators
Market Signals| Indicator | HGV | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 43.95 | 57.78 |
| Support Level | $43.95 | $12.10 |
| Resistance Level | $49.77 | N/A |
| Average True Range (ATR) | 1.84 | 1.29 |
| MACD | -0.53 | -0.06 |
| Stochastic Oscillator | 11.93 | 39.38 |
Price Performance
Historical ComparisonAbout HGV Hilton Grand Vacations Inc.
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.